Long-term Performance and Safety of Biodentine™ in Patients Treated for Endodontic Indications
Observational Clinical Trial, Prospective and Multicenter, Measuring the Long-term Performance and Safety of Biodentine™ in Patients Treated for Endodontic Indications
Septodont
160 participants
Nov 8, 2021
OBSERVATIONAL
Conditions
Summary
In this observational, retro-prospective, and multicenter PMCF clinical investigation, Biodentine™, an active dentine substitute for professional dental use only, is evaluated at 10 years post-treatment, in its endodontic indications as followed: * Repair of root or furcation perforations. * Repair of root resorptions (internal and external). * Root-end filling in endodontic surgery (retrograde filling). * Apexification (tooth with open apex). * Revitalization procedure by means of revascularization. Evaluation is done through a 10-year post-treatment follow-up with collection of radiographic, clinical examination and safety data.
Eligibility
Inclusion Criteria6
- Male or female, adult or child with permanent study tooth (immature or mature)
- Study tooth treated with an endodontic microsurgery using Biodentine™: all microsurgery including root end-filling, external or internal root resorption repair, root and furcation perforation repair and apexification
- Study tooth treated at least 1 year and no more than 5.5 years before inclusion visit
- Availability of baseline radiographic image of the study tooth
- Patient affiliated to national health insurance
- Patient informed about the study and who confirms his/her consent to participate to the study
Exclusion Criteria4
- Patient treated with anti-cancer therapy in the 5 years prior to the treatment
- Uncontrolled systemic disease 1 month prior to the treatment
- Development of a cancer or a systemic disease just after the treatment
- Participation to an interventional clinical trial at the time of the treatment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Biodentine™ is a bioactive dentin substitute from the " Active Biosilicate Technology® " innovation. Study participants were treated from 1 year to 5,5 years ago through an endodontic microsurgery using Biodentine™ used in its endodontic indications, i.e., root end-filling, external or internal root resorption repair, root and furcation perforation repair, apexification, and revitalization procedure by means of revascularization.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05084742